[PDF][PDF] The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

J Galon, HK Angell, D Bedognetti, FM Marincola - Immunity, 2013 - cell.com
Numerous analyses of large patient cohorts identified specific patterns of immune activation
associated with patient survival. We established these as the immune contexture …

Tumour immunity: effector response to tumour and role of the microenvironment

A Mantovani, P Romero, AK Palucka, FM Marincola - The lancet, 2008 - thelancet.com
Substantial evidence shows that inflammation promotes oncogenesis and, occasionally,
participates in cancer rejection. This paradox can be accounted for by a dynamic switch from …

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma

G Erdag, JT Schaefer, ME Smolkin, DH Deacon… - Cancer research, 2012 - AACR
Immune cells infiltrating the microenvironment of melanoma metastases may either limit or
promote tumor progression, but the characteristics that distinguish these effects are obscure …

[HTML][HTML] Immune regulation of cancer

ML Disis - Journal of Clinical Oncology, 2010 - ncbi.nlm.nih.gov
Innate and adaptive immune system cells play a major role in regulating the growth of
cancer. Although it is commonly thought that an immune response localized to the tumor will …

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer

S Adams, L Kozhaya, F Martiniuk, TC Meng… - Clinical Cancer …, 2012 - AACR
Purpose: Skin metastases of breast cancer remain a therapeutic challenge. Toll-like receptor
7 agonist imiquimod is an immune response modifier and can induce immune-mediated …

[HTML][HTML] Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells

M Orecchioni, D Bedognetti, L Newman… - Nature …, 2017 - nature.com
Understanding the biomolecular interactions between graphene and human immune cells is
a prerequisite for its utilization as a diagnostic or therapeutic tool. To characterize the …

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis

W Hendrickx, I Simeone, S Anjum, Y Mokrab… - …, 2017 - Taylor & Francis
Cancer immunotherapy is revolutionizing the clinical management of several tumors, but
has demonstrated limited activity in breast cancer. The development of more effective …

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma

A Ribas, B Comin-Anduix, B Chmielowski, J Jalil… - Clinical Cancer …, 2009 - AACR
Purpose: Tumor antigen–loaded dendritic cells (DC) are believed to activate antitumor
immunity by stimulating T cells, and CTL-associated antigen 4 (CTLA4)–blocking antibodies …

Dendritic cells and immunity against cancer

K Palucka, H Ueno, J Fay… - Journal of internal …, 2011 - Wiley Online Library
Palucka K, Ueno H, Fay J, Banchereau J (Baylor Institute for Immunology Research and
Sammons Cancer Center, Baylor University Medical Center, Dallas, TX; and Department of …

[HTML][HTML] Gene expression profiling of cutaneous wound healing

K Deonarine, MC Panelli, ME Stashower, P Jin… - Journal of translational …, 2007 - Springer
Background Although the sequence of events leading to wound repair has been described
at the cellular and, to a limited extent, at the protein level this process has yet to be fully …